This study is being conducted to gather long-term data of the performance of the Miromatrix Biological Mesh.
Miromatrix Medical Inc. has developed a new biologic mesh, called MIROMESH®. MIROMESH received FDA 510(k) clearance with an indication for reinforcement of soft tissue on March 31, 2014 under K134033. Miromatrix Biologic Mesh is a non cross-linked, acellular surgical mesh that is derived from the highly vascularized porcine liver. This study will serve to provide clinicians with high-quality clinical data in order to provide them with a higher degree of confidence when selecting MIROMESH for ventral hernia repair.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Sarasota Memorial Hospital
Sarasota, Florida, United States
University of Kentucky
Lexington, Kentucky, United States
Penn State Hershey Medical Center
Hershey, Pennsylvania, United States
University of Wisconsin
Madison, Wisconsin, United States
Hernia recurrence requiring surgical intervention
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.